News
08-30-2017, 12:12 PM
Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive (ER-positive) breast cancer in its tracks.
More... (https://www.news-medical.net/news/20170830/Researchers-synthesizing-new-first-in-class-drug-to-stop-growth-of-ER-positive-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20170830/Researchers-synthesizing-new-first-in-class-drug-to-stop-growth-of-ER-positive-breast-cancer.aspx)